avyantra.com

What It Is

Avyantra Health Technologies Pvt Ltd is an Indian healthcare technology company whose mission is to deliver innovative, affordable, and accessible medical solutions for developing countries and resource-constrained populations. Its enterprise software angle is mainly reflected in PreSCo: a machine-learning platform/app for early assessment of neonatal sepsis, used to generate predictive risk scores, analytical reports, and dashboards, and to support antibiotic-use decisions. Another product, Periton Safe, is more of a medical hardware offering: an IoT enabled automated peritoneal dialysis device.

Core Features and Deployment

PreSCo focuses on infection-risk scenarios for newborns aged 0-28 days and infants under 1 year old. It uses machine-learning algorithms to provide rapid, non-invasive neonatal sepsis risk assessment. The website also describes it as a cloud-based data analytics platform, suggesting it is primarily delivered as a cloud/web application, but it does not disclose whether private or on-premises deployment is supported. Periton Safe is designed for automated peritoneal dialysis at home. It can continuously monitor patient adherence and performance parameters, and includes sensors for early detection of peritonitis.

Pricing, Trial, and Payments

The website mentions “Subscription Plans,” and its refund terms also refer to service plan fees, taxes, convenience fees, and total amounts, indicating that PreSCo has at least some form of subscription or service-plan model. However, public pages do not provide specific plans, pricing, usage limits, trial periods, or a free tier. One important point is that its cancellation and refund policy appears strict: refunds are not processed after payment confirmation, and cancellation requests are not accepted after payment.

Security, Compliance, and Enterprise Readiness

The privacy policy states that the company processes personal data in accordance with India’s IT Act, 2000 and relevant national and state laws. It collects names, email addresses, phone numbers, identity documents, hospital details, and sepsis-related health data of newborns and mothers. The company says it uses physical, electronic, procedural, technical, and organizational measures to protect data, and restricts access to personnel with a business need. However, no HIPAA, ISO, SOC, or other healthcare/cloud security certifications were found, nor is there disclosure of APIs, developer documentation, hospital HIS/EMR integration capabilities, role-based permissions, or other enterprise-grade features.

Pros, Cons, and Best Fit

The key strength is a clearly defined problem focus, targeting high-value healthcare scenarios such as neonatal sepsis and dialysis, especially in low-resource, rural, and primary-care settings. The downsides are limited public commercial information and a lack of transparency around software maturity, integration ecosystem, compliance certifications, and service SLAs. In addition, the disclaimer states that the application is intended only for basic screening and educational purposes and cannot replace medical advice.

China Access and Alternatives

Based on the crawled text, it is not possible to determine access availability, network stability, or payment usability from mainland China, so china_access is marked as unknown. For deployment in Chinese medical institutions, key issues would include cross-border data transfer, regulation of medical devices/AI-assisted diagnosis, Chinese-language support, and integration with local hospital systems. Alternative directions could include domestic solutions in hospital information systems, clinical decision support, AI-assisted diagnosis, and remote dialysis.